Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Change in Cash (2016 - 2025)

AtriCure (ATRC) has disclosed Change in Cash for 16 consecutive years, with $19.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Cash rose 356.93% to $19.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $44.7 million, a 16.39% increase, with the full-year FY2025 number at $44.7 million, up 16.39% from a year prior.
  • Change in Cash was $19.6 million for Q4 2025 at AtriCure, down from $30.1 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $43.4 million in Q1 2021 to a low of -$27.7 million in Q3 2021.
  • A 5-year average of $6.3 million and a median of $6.5 million in 2021 define the central range for Change in Cash.
  • Peak YoY movement for Change in Cash: soared 746.66% in 2021, then plummeted 305.12% in 2024.
  • AtriCure's Change in Cash stood at $3.8 million in 2021, then soared by 146.18% to $9.3 million in 2022, then tumbled by 59.98% to $3.7 million in 2023, then tumbled by 305.12% to -$7.6 million in 2024, then soared by 356.93% to $19.6 million in 2025.
  • Per Business Quant, the three most recent readings for ATRC's Change in Cash are $19.6 million (Q4 2025), $30.1 million (Q3 2025), and $17.9 million (Q2 2025).